Boehringer Ingelheim has announced that it intends to make drug data from clinical trials stemming back to 1998 accessible as part of efforts to improve research transparency within the industry. The move is part of a collaboration with fellow pharma companies Sanofi, GlaxoSmithKline, Novartis, Roche and ViiV Healthcare on an online platform to handle requests from researchers for trial data. Boehringer’s chairman Dr Andreas Barner made the announcement at Boehringer’s annual company meeting yesterday, following up from a commitment to transparency announced at the same meeting in 2013.
Help employers find you! Check out all the jobs and post your resume.
